ASKA Pharmaceutical Co., Ltd. Stock Japan Exchange
Equities
4514
JP3541200006
Pharmaceuticals
Sales 2024 * | 63.28B 414M | Sales 2025 * | 64.65B 422M | Capitalization | 64.22B 420M |
---|---|---|---|---|---|
Net income 2024 * | 6.47B 42.25M | Net income 2025 * | 4.89B 31.98M | EV / Sales 2024 * | 0.76 x |
Net cash position 2024 * | 16.35B 107M | Net cash position 2025 * | 20.83B 136M | EV / Sales 2025 * | 0.67 x |
P/E ratio 2024 * |
9.92
x | P/E ratio 2025 * |
13.1
x | Employees | 747 |
Yield 2024 * |
1.76% | Yield 2025 * |
2.12% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
President | 72 | 21-03-31 | |
Kiyohiko Tamura
ADM | Chief Administrative Officer | - | - |
Kunihiro Gunji
CMP | Compliance Officer | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 72 | 21-03-31 | |
Atsushi Maruo
BRD | Director/Board Member | 65 | 21-03-31 |
Director/Board Member | 75 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |